Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             124 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Adherence to Evidence-Based Therapies in Heart Failure Bhatt, Ankeet S.

12 p. 887-889
artikel
2 Adiposity and Incident Heart Failure and its Subtypes Rao, Vishal N.
2018
12 p. 999-1007
artikel
3 Advanced Heart Failure Costanzo, Maria Rosa

12 p. 938-940
artikel
4 Age Differences in Effects of Sacubitril/Valsartan on Cardiac Remodeling, Biomarkers, and Health Status Murphy, Sean P.

12 p. 976-988
artikel
5 Age-Related Divergence of Risk-Benefit Relationship of Spironolactone Treatment for Heart Failure With Preserved Ejection Fraction ∗ Kitzman, Dalane W.

12 p. 1029-1031
artikel
6 Aging Wettersten, Nicholas

12 p. 1066-1068
artikel
7 Aldosterone Sbolli, Marco

12 p. 1021-1023
artikel
8 Amino-Terminal Pro-B-Type Natriuretic Peptide for Diagnosis and Prognosis in Patients With Renal Dysfunction Schaub, Jennifer A.
2015
12 p. 977-989
13 p.
artikel
9 Applying Network Meta-Analysis to Cardiovascular Outcome Trials of Glucose-Lowering Drugs Zheng, Sean L.
2018
12 p. 1052
artikel
10 Association of 30-Day Readmission Metric for Heart Failure Under the Hospital Readmissions Reduction Program With Quality of Care and Outcomes Pandey, Ambarish
2016
12 p. 935-946
12 p.
artikel
11 Association of Early Blood Pressure Decrease and Renal Function With Prognosis in Acute Heart Failure Matsue, Yuya

12 p. 890-903
artikel
12 Association of Nasal Mucosal Vascular Alterations, Gastrointestinal Arteriovenous Malformations, and Bleeding in Patients With Continuous-Flow Left Ventricular Assist Devices Patel, Snehal R.
2016
12 p. 962-970
9 p.
artikel
13 Associations Between Depressive Symptoms and HFpEF-Related Outcomes Chandra, Alvin

12 p. 1009-1020
artikel
14 Aviation Emergencies for Heart Failure Cardiologists O’Connor, Christopher M.
2018
12 p. 1047-1048
artikel
15 Balancing Expectations Sarma, Satyam

12 p. 928-930
artikel
16 Calorie Intake, Post-Discharge Outcomes in Heart Failure, and Food Insecurity Mehmood, Muddassir

12 p. 1052
artikel
17 Cause of Death in Patients With Acute Heart Failure Loungani, Rahul S.

12 p. 999-1008
artikel
18 Changing U.S. Heart Failure Research Culture: Part 2—Recognizing Frontline Investigators and Coordinators O’Connor, Christopher M.

12 p. 1050-1051
artikel
19 Chloride in Heart Failure Zandijk, Arietje J.L.

12 p. 904-915
artikel
20 Clinical Outcomes After Left Ventricular Assist Device Implantation in Older Adults Caraballo, Cesar

12 p. 1069-1078
artikel
21 Clinical Outcomes With a Fully Magnetically Levitated Left Ventricular Assist Device Among Women and Men Ramu, Bhavadharini

12 p. 1692-1704
artikel
22 Closing the Gender Gap in Cardiogenic Shock Kalantari, Sara

12 p. 1754-1756
artikel
23 Cognitive Decline in Heart Failure Kalogeropoulos, Andreas P.

12 p. 1054-1055
artikel
24 Cognitive Decline Over Time in Patients With Systolic Heart Failure Lee, Tetz C.

12 p. 1042-1053
artikel
25 Correction
12 p. 944
artikel
26 Correction
12 p. 1059
artikel
27 Correction
12 p. 1058-1059
artikel
28 Correction
12 p. 1057
artikel
29 Correction
12 p. 1773
artikel
30 Delayed Response to Cardiac Resynchronization Ellenbogen, Kenneth A.
2015
12 p. 998-1000
3 p.
artikel
31 Development of a Decision Aid for Patients With Advanced Heart Failure Considering a Destination Therapy Left Ventricular Assist Device Thompson, Jocelyn S.
2015
12 p. 965-976
12 p.
artikel
32 Diuretic Strategies and Renal Dysfunction in Heart Failure With Preserved Ejection Fraction Reed, Brent N.
2018
12 p. 1049-1050
artikel
33 Estimating the Lifetime Benefits of Treatments for Heart Failure Ferreira, João Pedro

12 p. 984-995
artikel
34 Finding the Right Time and Place to Vent ∗ Stewart, Garrick C.
2018
12 p. 1044-1046
artikel
35 Frailty Among Older Decompensated Heart Failure Patients Pandey, Ambarish

12 p. 1079-1088
artikel
36 Frailty Is Intertwined With Heart Failure Pandey, Ambarish

12 p. 1001-1011
artikel
37 Frequency of Transition From Stage A to Stage B Heart Failure After Initiating Potentially Cardiotoxic Chemotherapy Jones, Deanna N.
2018
12 p. 1023-1032
artikel
38 From Reactivity to Proactivity Desai, Nihar R.

12 p. 1035-1037
artikel
39 Full Issue PDF
12 p. e1-e121
artikel
40 Functional and Symptomatic Clinical Trial Endpoints Psotka, Mitchell A.

12 p. 889-901
artikel
41 Health Care Use Before First Heart Failure Hospitalization Anderson, Kim

12 p. 1024-1034
artikel
42 Health Status Predicts Short- and Long-Term Risk of Composite Clinical Outcomes in Acute Heart Failure Hu, Danli

12 p. 861-873
artikel
43 Heart Failure and Comorbidities RuDusky, Basil M.
2015
12 p. 1003-
1 p.
artikel
44 Heart Failure “End Result Cards” O’Connor, Christopher M.
2015
12 p. 1001-1002
2 p.
artikel
45 Heart Failure in Women Bozkurt, Biykem

12 p. 1767-1768
artikel
46 Heart Failure Prevention in Older Patients Using Intensive Blood Pressure Reduction Upadhya, Bharathi

12 p. 1032-1041
artikel
47 Heart Failure With Atrial Fibrillation Qian, Yuanyuan

12 p. 1769
artikel
48 Hemodynamically-Guided Management of Heart Failure Across the Ejection Fraction Spectrum Zile, Michael R.

12 p. 931-944
artikel
49 HFrEF Progress for Women Remains Stagnant ∗ Stempien-Otero, April

12 p. 1739-1741
artikel
50 Home Health Care Use and Post-Discharge Outcomes After Heart Failure Hospitalizations Sterling, Madeline R.

12 p. 1038-1049
artikel
51 How to Initiate and Uptitrate GDMT in Heart Failure Bozkurt, Biykem

12 p. 992-995
artikel
52 Hypertension, Obesity, Diabetes, and Heart Failure–Free Survival Ahmad, Faraz S.
2016
12 p. 911-919
9 p.
artikel
53 Impact of Age on Comorbidities and Outcomes in Heart Failure With Reduced Ejection Fraction Regan, Jessica A.

12 p. 1056-1065
artikel
54 Impact of Coronary Artery Disease in Women With Newly Diagnosed Heart Failure and Reduced Ejection Fraction Nielsen, Roni Ranghoej

12 p. 1653-1663
artikel
55 Impact of Female Sex on Cardiogenic Shock Outcomes Ton, Van-Khue

12 p. 1742-1753
artikel
56 Influence of Age on Efficacy and Safety of Spironolactone in Heart Failure Vardeny, Orly

12 p. 1022-1028
artikel
57 Influence of Baseline Physical Activity Level on Exercise Training Response and Clinical Outcomes in Heart Failure Mediano, Mauro F.F.
2018
12 p. 1011-1019
artikel
58 Influence of NT-proBNP on Efficacy of Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction Myhre, Peder L.

12 p. 902-913
artikel
59 Inotropes and Mortality Guglin, Maya
2018
12 p. 1050-1051
artikel
60 Inside This Issue 2015
12 p. A14-A16
nvt p.
artikel
61 Insights From HeartLogic Multisensor Monitoring During the COVID-19 Pandemic in New York City Mitter, Sumeet S.

12 p. 1053-1055
artikel
62 Learning From Our Predictions Stewart, Garrick C.
2016
12 p. 959-961
3 p.
artikel
63 Living Without Heart Failure Wang, Thomas J.
2016
12 p. 920-922
3 p.
artikel
64 Long-Term Echocardiographic Response to Cardiac Resynchronization Therapy in Initial Nonresponders Burns, Kevin V.
2015
12 p. 990-997
8 p.
artikel
65 Look After You Leap ∗ Whellan, David J.

12 p. 925-926
artikel
66 Maternal and Pregnancy Outcomes Following Heart Transplantation in the United States Craig, Amanda M.

12 p. 1666-1674
artikel
67 miRNAs and Mitral Interventions in Heart Failure Patanè, Salvatore

12 p. 1771
artikel
68 MRAs in Elderly HF Patients Ferreira, João Pedro

12 p. 1012-1021
artikel
69 N-1 and Sequencing Clinical Heart Failure Trials O’Connor, Christopher M.

12 p. 1089-1090
artikel
70 Natriuretic Peptide–Based Risk Prediction and Assessment of Treatment Effect Tanaka, Atsushi

12 p. 941-942
artikel
71 Natriuretic Peptides Grodin, Justin L.

12 p. 914-917
artikel
72 Not Your Mother’s FDA O’Connor, Christopher M.
2016
12 p. 978-
1 p.
artikel
73 Obesity Status and Physical Rehabilitation in Older Patients Hospitalized With Acute HF Peters, Anthony E.

12 p. 918-927
artikel
74 Outcomes of Multiple Listing for Adult Heart Transplantation in the United States Givens, Raymond C.
2015
12 p. 933-941
9 p.
artikel
75 Outpatient Management of Heart Failure During the COVID-19 Pandemic After Adoption of a Telehealth Model Sammour, Yasser

12 p. 916-924
artikel
76 Paradoxical Vessel Remodeling of the Proximal Segment of the Left Anterior Descending Artery Predicts Long-Term Mortality After Heart Transplantation Okada, Kozo
2015
12 p. 942-952
11 p.
artikel
77 Patient-Centered Measures of Treatment Benefit ∗ Leifer, Eric S.

12 p. 996-998
artikel
78 Physical Activity and Incidence of Heart Failure in Postmenopausal Women LaMonte, Michael J.
2018
12 p. 983-995
artikel
79 Physical Activity, Fitness, and Obesity in Heart Failure With Preserved Ejection Fraction Pandey, Ambarish
2018
12 p. 975-982
artikel
80 Pivotal Role of Excess Intra-Abdominal Adipose in the Pathogenesis of Metabolic/Obese HFpEF ∗ Kitzman, Dalane W.
2018
12 p. 1008-1010
artikel
81 Prediction of Survival After Implantation of a Fully Magnetically Levitated Left Ventricular Assist Device Mehra, Mandeep R.

12 p. 948-959
artikel
82 Pregnancy as a Sentinel Event DeFilippis, Ersilia M.

12 p. 1675-1677
artikel
83 Pre-Operative Right Ventricular Dysfunction Is Associated With Gastrointestinal Bleeding in Patients Supported With Continuous-Flow Left Ventricular Assist Devices Sparrow, Christopher T.
2015
12 p. 956-964
9 p.
artikel
84 Prevalence, Profile, and Prognosis of Severe Obesity in Contemporary Hospitalized Heart Failure Trial Populations Joyce, Emer
2016
12 p. 923-931
9 p.
artikel
85 Proteomic Profiling in Patients With Peripartum Cardiomyopathy Kodogo, Vitaris

12 p. 1708-1725
artikel
86 Proteomic Signatures of Peripartum Cardiomyopathy Adamo, Luigi

12 p. 1726-1728
artikel
87 Quality of Life Always Matters ∗ Psotka, Mitchell A.

12 p. 874-875
artikel
88 Reply Murad, Khalil
2015
12 p. 1003-1004
2 p.
artikel
89 Reply Kramer, Caroline K.
2018
12 p. 1052-1053
artikel
90 Reply Nizamic, Tiana Jespersen
2018
12 p. 1051
artikel
91 Reply Sharma, Kavita
2018
12 p. 1050
artikel
92 Reply Gentile, Francesco

12 p. 942-943
artikel
93 Reply Hummel, Scott L.

12 p. 1052-1053
artikel
94 Reply DeFilippis, Ersilia M.

12 p. 1055-1056
artikel
95 Reply Chieng, David

12 p. 1770
artikel
96 Reply Lander, Matthew M.

12 p. 1772
artikel
97 Sacubitril/Valsartan Adherence and Postdischarge Outcomes Among Patients Hospitalized for Heart Failure With Reduced Ejection Fraction Carnicelli, Anthony P.

12 p. 876-886
artikel
98 Safety of Right and Left Ventricular Endomyocardial Biopsy in Heart Transplantation and Cardiomyopathy Patients Bermpeis, Konstantinos

12 p. 963-973
artikel
99 Severe Maternal Morbidity According to Mode of Delivery Among Pregnant Patients With Cardiomyopathies Meng, Marie-Louise

12 p. 1678-1689
artikel
100 Severe Obesity and Acute Decompensated Heart Failure Alpert, Martin A.
2016
12 p. 932-934
3 p.
artikel
101 Sex Differences in CardioMEMS Utilization and Impact on Readmissions and Mortality in Heart Failure Patients Markson, Favour

12 p. 1760-1762
artikel
102 Sex Differences in Heart Failure With Reduced Ejection Fraction in the GALACTIC-HF Trial Pabon, Maria

12 p. 1729-1738
artikel
103 Sex Differences in Myocardial Histology, Gene Expression, and Myocardial Recovery in Recent-Onset Cardiomyopathy Koczo, Agnes

12 p. 1757-1759
artikel
104 Sex, Temporary Mechanical Circulatory Support, and Heart Transplantation Enríquez-Vázquez, Daniel

12 p. 1763-1766
artikel
105 Standardized Definitions for Evaluation of Heart Failure Therapies: Scientific Expert Panel From the Heart Failure Collaboratory and Academic Research Consortium Abraham, William T.

12 p. 961-972
artikel
106 Targeting All Heart Failure Patients With Exercise Training Hambrecht, Rainer
2018
12 p. 1020-1022
artikel
107 The Changing Face of First-Year Intravascular Ultrasonography in Heart Transplantation ∗ Kobashigawa, Jon A.
2015
12 p. 953-955
3 p.
artikel
108 The FDA in the 21st Century Hillebrenner, Matthew
2016
12 p. 974-977
4 p.
artikel
109 The HeartMate 3 Risk Score Stehlik, Josef

12 p. 960-962
artikel
110 The HeartMate Risk Score Identifies Patients With Similar Mortality Risk Across All INTERMACS Profiles in a Large Multicenter Analysis Adamo, Luigi
2016
12 p. 950-958
9 p.
artikel
111 The Heart of the Matter Barghash, Maya H.

12 p. 1664-1665
artikel
112 The Pressure for Progress in Heart Failure ∗ Abraham, Jacob

12 p. 945-947
artikel
113 “To B or Not to B”…That Is the Question Lenihan, Daniel J.
2018
12 p. 1033-1034
artikel
114 Understanding and Eliminating Disparities for Women Needing Mechanical Circulatory Support ∗ Bhardwaj, Anju

12 p. 1705-1707
artikel
115 Unloading of the Left Ventricle During Venoarterial Extracorporeal Membrane Oxygenation Therapy in Cardiogenic Shock Schrage, Benedikt
2018
12 p. 1035-1043
artikel
116 Uptake of Newer Guideline-Directed Therapies in Heart Failure Patients With Diabetes or Chronic Kidney Disease Canonico, Mario Enrico

12 p. 989-991
artikel
117 Use of Cardiopulmonary Stress Testing for Patients With Unexplained Dyspnea Post–Coronavirus Disease Mancini, Donna M.

12 p. 927-937
artikel
118 Utility of Restricted Mean Survival Time Analysis for Heart Failure Clinical Trial Evaluation and Interpretation Perego, Carlotta

12 p. 973-983
artikel
119 VAD Strueber, Martin
2016
12 p. 971-973
3 p.
artikel
120 Vaginal Delivery Remains the Preferred Mode of Delivery for Almost All Women With Cardiovascular Disease ∗ Lindley, Kathryn J.

12 p. 1690-1691
artikel
121 Walking Away From Heart Failure ∗ Jessup, Mariell
2018
12 p. 996-998
artikel
122 When and for Whom Should We Use SGLT2 Inhibitors in HFrEF? Tanaka, Atsushi

12 p. 1056
artikel
123 When Tissue Matters Cooper Jr., Leslie T.

12 p. 974-975
artikel
124 Whose Metric Is It, Anyway? Konstam, Marvin A.
2016
12 p. 947-949
3 p.
artikel
                             124 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland